Skip to content

Clinical trials

Phase 1/2 Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphadenopathy Phase: Phase 1/2 Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20122

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Koneti Rao1
M.D. Anderson Cancer Center1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphadenopathy3
Autoimmune Lymphoproliferative Syndrome1
Autoimmune Pancreatitis1
Hypersplenism1
Meningitis1
Orbital Pseudotumor1
Prostatic Neoplasms1
Retroperitoneal Fibrosis1
Sialadenitis1
Splenomegaly1

Trials

Showing 51 to 3 of 3. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.